Place an order request to the broker. The personal manager will contact you to confirm the order.

Order Summary

Asset: Select instrument
Quantity: -
Price per Unit: ? This price is indicative and shown for informational purposes only. The final execution price may change. -
Total Amount: -

Order Expiration

Order remains active until you cancel it or it gets filled

Order expires at the end of the selected day

Order Placed Successfully

Your order has been submitted! Our team will contact you shortly to confirm.

Order Type: -
Asset: -
Quantity: -
Total Amount: -
Manually record a past trade to keep your portfolio up to date. This helps track your P&L accurately.
Total Amount: $0.00

Trade Added Successfully

Trade recorded! Your portfolio data will be recalculated.

Type: -
Asset: -
Quantity: -
Price: -
Total: -

Chat Options

Web Search
Search the internet for recent information
Portfolio Context
Include your portfolio in the conversation
Market Data
Access real-time market information
Watchlist Context
Include your watchlist companies

Amundi Fds US Equity Rsrch Val I USD ADD

0P0001HV5H
ISIN: LU1894684825
Name: US Equity Value
1D --
5D --
1M --
6M --
YTD --

Latest Analysis Report

Key Updates

US Equity Value has declined 2.98% to $1,710.23 since the March 6 report, extending the correction that began in mid-February and now marking a cumulative 7.35% decline from the February 12 peak of $1,845.63. Despite this near-term weakness, the fund maintains a modest 0.69% year-to-date gain, supported by a 4.17% six-month advance. The recent period has seen significant industry activity with three major developments: Brown Advisory's launch of a modern value capability under Nick Kirrage's leadership, Fundstrat Capital's GRNY ETF rebalance toward quality cyclical and value stocks, and Davis Select U.S. Equity ETF surpassing $1 billion in assets. These developments signal continued institutional interest in value strategies despite current price pressure, though the persistent downward momentum suggests near-term headwinds remain dominant.

Current Trend

The asset is experiencing a pronounced correction phase, with consecutive negative reports since mid-February. The 2.98% decline since March 6 represents the continuation of selling pressure that has now erased most of the year-to-date gains accumulated through early February. The 7.19% one-month decline indicates accelerating weakness, while the 0.69% YTD performance demonstrates the fragility of the support level established in early 2026. The 4.17% six-month gain provides a longer-term perspective showing relative resilience, but the current trajectory suggests the $1,710 level is under pressure. The price has now fallen approximately 7.35% from the February 12 high of $1,845.63, establishing a clear downtrend with lower highs and lower lows across all short-term timeframes.

Investment Thesis

The value investment thesis centers on identifying quality companies trading below intrinsic value during periods of market dislocation or cyclical weakness. The recent industry developments underscore this approach: Brown Advisory's launch emphasizes a "modern behavioral value investing approach" targeting companies below intrinsic value, while Fundstrat's GRNY ETF rebalance toward "quality cyclical and value stocks" with $4.1 billion in AUM demonstrates institutional conviction in the value factor. Davis Select U.S. Equity ETF's milestone of surpassing $1 billion in assets further validates the long-term appeal of concentrated, high-conviction value strategies. The thesis assumes that systematic undervaluation creates opportunities for mean reversion as markets recognize fundamental quality, supported by disciplined risk management and contrarian positioning during periods of market uncertainty.

Thesis Status

The investment thesis remains structurally intact despite near-term price deterioration. The three recent announcements demonstrate robust institutional commitment to value strategies, with combined assets exceeding $7.4 billion across the highlighted funds ($4.1B for GRNY, $2.3B for Davis Advisors' ETF suite, and $1B+ for DUSA alone). Brown Advisory's decision to launch a dedicated value capability with a senior team from Schroders signals confidence in the strategy's long-term viability. However, the persistent price weakness suggests the market is currently prioritizing other factors over value characteristics, potentially reflecting concerns about economic growth, interest rate trajectories, or sector rotation dynamics. The 7.19% one-month decline indicates that near-term catalysts for value outperformance remain absent, creating a divergence between institutional positioning and market sentiment. The thesis requires patience as the gap between price and intrinsic value widens, which historically creates more compelling entry points but also extends drawdown periods.

Key Drivers

Three primary developments are shaping the value investment landscape. First, Brown Advisory's launch of a modern value capability under Nick Kirrage represents a significant vote of confidence in value strategies, with the firm deploying experienced personnel and launching the BAIV ETF on Nasdaq. The "data-driven, contrarian approach with integrated behavioral triggers" suggests evolution in value methodology beyond traditional metrics. Second, Fundstrat Capital's GRNY ETF rebalance toward quality cyclical and value stocks, including additions like Amgen, Chevron, and Northrop Grumman while removing growth names like CrowdStrike and Palo Alto Networks, indicates a tactical shift favoring defensive quality and value characteristics. The fund's growth to $4.1 billion in AUM demonstrates significant investor appetite. Third, Davis Select U.S. Equity ETF's milestone of surpassing $1 billion in assets validates the high-conviction, benchmark-agnostic approach to U.S. large-cap value investing. These developments collectively suggest institutional capital is positioning for a value cycle, though the timing of market recognition remains uncertain given current price action.

Technical Analysis

US Equity Value has established a clear downtrend since the February 12 peak at $1,845.63, with the current price of $1,710.23 representing a 7.35% decline and testing support levels not seen since early 2026. The asset broke below the $1,762.72 level from the March 6 report, indicating weakening support and potential for further downside. The 2.98% five-day decline matches the decline since the last report, suggesting consolidation around current levels rather than accelerating selling pressure. However, the 7.19% one-month decline represents the steepest drawdown in the provided timeframe, indicating momentum remains negative. The 0.69% YTD gain provides a critical support zone; a break below this level would turn the year negative and likely trigger additional technical selling. Resistance has formed at $1,762.72 (March 6 level) and more significantly at $1,806.63 (February 13 level). The 4.17% six-month gain suggests the $1,640-$1,650 range may provide longer-term support if current weakness persists. Volume and momentum indicators would be necessary to assess whether this represents capitulation or the beginning of a more extended correction.

Bull Case

Bear Case

  • Persistent downward momentum with 7.19% one-month decline and consecutive negative reports since mid-February indicates systematic selling pressure that has overwhelmed any positive impact from institutional product launches, suggesting fundamental headwinds or broad market rotation away from value factors.
  • The 2.98% decline since March 6 report extending the correction phase demonstrates inability to establish support despite reaching oversold levels, indicating potential for further downside as technical support levels continue to fail and momentum remains decidedly negative across all short-term timeframes.
  • Fundstrat's deletion of high-growth technology names like CrowdStrike and Palo Alto Networks in favor of traditional value stocks may signal peak positioning in value factors, with institutional herding creating crowded trades vulnerable to reversal if economic conditions deteriorate or growth reasserts dominance.
  • The minimal 0.69% YTD gain despite significant institutional product launches and positive six-month performance suggests the value factor is struggling to generate alpha in the current market environment, raising questions about whether structural market changes have diminished the efficacy of traditional value strategies.
  • Launch of new value products during a period of declining prices may indicate poor market timing, with institutional capital potentially entering at inopportune levels and facing extended drawdown periods before the value cycle materializes, creating redemption pressure if performance disappoints.

Unlock AI Insights for this stock

Get personalized alerts, AI-powered analysis, and market insights delivered to you.

Real-time stock analysis & forecasts
Personalized watchlist & price alerts
AI trading ideas with price targets
Portfolio tracking & insights
Track this stock — free

Recent News

No recent news available.

CapPilot is AI-powered and can make mistakes. Please double-check responses.

CapPilot leverages generative AI to distill market insights and analysis, as well as answer your questions in chat. While we work hard to ensure accuracy, AI-generated content may occasionally contain inaccuracies or outdated information.

We value your feedback — reporting errors helps us continuously improve.

Never miss a move — get AI reports & price alerts for this stock delivered free Create Free Account